
Antengene Corporation Investor Relations Material
Latest events

H1 2025
22 Aug, 2025

Study Update
20 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Antengene Corporation Limited
Access all reports
Antengene Corporation Limited is a China-based biotechnology company focused on the discovery, development, and commercialization of therapies for cancer and other life-threatening diseases. Antengene's work spans early-stage discovery through clinical development and regulatory approvals, with a focus on targeted therapies and immuno-oncology. It is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Key slides for Antengene Corporation Limited


H1 2025
Antengene Corporation Limited


H1 2025
Antengene Corporation Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
6996
Country
🇭🇰 Hong Kong